Valbury Asia Futures

Here's the latest from Wealthy Retirement... ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

AN OXFORD CLUB PUBLICATION

SPONSORED Volatility Got You Down? Overnight Trades Could Be the Answer One community made one special kind of trade... Went to sleep... And woke up to gains as high as 123% on General Electric... 133% on Kellogg... 116% on Pinterest... and 188% on FedEx. Learn How to Wake Up to Winners - Start Now!

– ON THE AIR –

It's not easy to pick giant biotech winners... But after covering the sector for 21 years, Chief Income Strategist Marc Lichtenfeld has gotten pretty good at it. He's closed out some big winners - like a 419% gain on Celldex Therapeutics (Nasdaq: CLDX), a 226% gain on Myovant Sciences in just two months and a more than 2,000% gain on AbbVie (NYSE: ABBV) options. Would you like to score big gains like that? In this State of the Market, Marc outlines what he looks for to help pick big biotech winners. WATCH STATE OF THE MARKET

– THE BIG REVEAL –

Last year, Marc reviewed the dividend safety of this business development company (BDC). At the time, it yielded 8.7% and received a "B" for dividend safety. Today, the yield is 10% due to a decline in the stock price and an increase in the dividend. But can investors rely on a double-digit yield? Marc analyzes the dividend safety of this double-digit BDC in this Safety Net. REVEAL THE GRADE

– THE VALUE METER –

Contributing Analyst Jody Chudley is putting the entire market through The Value Meter. Year to date, the S&P 500 is up... But there's more to the story than meets the eye. Find out the valuation of the ENTIRE MARKET in this Value Meter.

– OVERHEARD –

Marc recently asked Wealthy Retirement readers, "What's the best financial advice you received as a young person?" We received some amazing feedback. Here's one of our favorites... Have an experience that you'd like to share with the team at Wealthy Retirement? Click here to send us a message.

SPONSORED My wife was skeptical... until I showed her my account balance. The Fed just created the single greatest income opportunity I've seen in nearly 20 years. I've put more than $1M of my own money into it. And plan to add another million! I even suggested my wife put her savings into it. That's because I fully expect this money move to hand me at least $1 MILLION within 5 years. My wife - an elementary school teacher - wanted me to be more cautious... until she saw my account had soared $79,487 in just one month. Now she's going in BIG too with $200K! If you act now (and I mean before July 26)... you could ride this wave with us. But hurry... once this opportunity is gone... we'll likely never see it again. Here's why...

– TOP ARTICLE –

THE SECRET TO HEALTHCARE INVESTING Everyone makes mistakes and pays "tuition" - the cost of learning - when they first start trading. Marc certainly has. Luckily, this one wasn't costly. But the lessons he's learned have helped shape the way he invests and trades - especially in the biotech and pharma sectors. Here's what you need to know BEFORE investing in biotech stocks.

– MORE FROM OUR NETWORK OF EXPERTS –

Should You Contemplate an Account Manager? >> Valuations Scream Trouble While Investors Shrug >> 3 Tropical Storm Trades >>

Facebook Twitter

SPONSORED Legendary Investor Goes "ALL-IN" He discovered Apple at $1... Netflix at $2... Now he's going all-in on what could be the next superstar. Details on his #1 pick right here...

You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist Wealthy Retirement | Unsubscribe © 2023 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 877.808.9795 | International: +1.443.353.4621 Oxfordclub.com

Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.